BRIEF published on 01/20/2026 at 15:58, 2 months 6 days ago Kopernik Global Investors crosses thresholds at EUROAPI Voting Rights Actions Crossing Thresholds EUROAPI Kopernik Global Investors
BRIEF published on 12/10/2025 at 17:50, 3 months 16 days ago Tristan Imbert Appointed as Independent Director at EUROAPI Pharmaceutical Industry Independent Director Audit Committee EUROAPI Tristan Imbert
PRESS RELEASE published on 12/10/2025 at 17:45, 3 months 16 days ago Tristan Imbert co-opted as Independent Director Tristan Imbert appointed Independent Director at EUROAPI, bringing expertise in pharmaceutical finance and strategy. Financial agenda includes FY 2025 results on 3 March 2026 and 2026 AGM on 27 May 2026 Financial Agenda Strategy EUROAPI Tristan Imbert Pharmaceutical Finance
BRIEF published on 09/18/2025 at 07:05, 6 months 8 days ago Science Based Targets initiative Validates EUROAPI's Climate Goals Sustainability GHG Emissions EUROAPI Climate Goals SBTi Validation
PRESS RELEASE published on 09/18/2025 at 07:00, 6 months 8 days ago Science Based Targets initiative (SBTi) validates EUROAPI’s near-term climate targets EUROAPI's near-term climate targets validated by the Science Based Targets initiative (SBTi) show significant reductions in greenhouse gas emissions, confirming alignment with the Paris Agreement Greenhouse Gas Emissions Science Based Targets Initiative Climate Targets Paris Agreement EUROAPI
BRIEF published on 06/30/2025 at 18:03, 8 months 26 days ago EUROAPI Divests Haverhill Site to Particle Dynamics Pharmaceutical EUROAPI FOCUS-27 Haverhill Sale Particle Dynamics
PRESS RELEASE published on 06/30/2025 at 17:58, 8 months 26 days ago EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan. Deal strengthens capabilities, market reach Acquisition EUROAPI FOCUS-27 Particle Dynamics Haverhill
BRIEF published on 06/19/2025 at 16:29, 9 months 7 days ago Goldman Sachs Crosses Thresholds in EUROAPI Voting Rights Actions Goldman Sachs Threshold Crossing EUROAPI
BRIEF published on 06/06/2025 at 16:03, 9 months 20 days ago EUROAPI General Assembly: Approval of Resolutions and Perspectives General Assembly EUROAPI Resolutions Approved R&D And CDMO Outlook 2023
BRIEF published on 06/04/2025 at 17:50, 9 months 22 days ago EUROAPI appoints Frédéric Robert as Sales Director for API and CDMO CDMO Appointment EUROAPI Frédéric Robert API Solutions
Published on 03/26/2026 at 16:20, 1 hour 46 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 5 hours 6 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 5 hours 6 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 5 hours 7 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 17:51, 14 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/26/2026 at 17:45, 21 minutes ago CTS EVENTIM exceeds EUR 3 billion in revenue for the first time, sustaining profitable growth
Published on 03/26/2026 at 17:20, 45 minutes ago EQS-Adhoc: Leifheit Aktiengesellschaft: Board of Management and Supervisory Board propose to the Annual General Meeting a capital increase from the company’s own funds, followed by an ordinary capital reduction
Published on 03/26/2026 at 17:19, 46 minutes ago Haier Smart Home Reports Full-Year 2025 Results: Global Revenue Surpasses RMB 300 Billion for the First Time; Net Profit Reaches a Record Highs
Published on 03/26/2026 at 07:30, 10 hours 36 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 23 hours 34 minutes ago Strong investment performance and active roll-out of our strategy